T.Man Pharmaceutical (SET:TMAN-R) - Stock Price, News & Analysis

TMAN-R Stock Overview

Manufactures and sells pharmaceuticals and health products.

TMAN-R fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	0/6
Past Performance	3/6
Financial Health	5/6
Dividends	0/6

Rewards

Price-To-Earnings ratio (16.1x) is below the Pharmaceuticals industry average (25.8x)

Risk Analysis

Shares are highly illiquid

T.Man Pharmaceutical Public Company Limited Competitors

Bangkok Lab And Cosmetic

SET:BLC

฿3.1b

Mega Lifesciences

SET:MEGA

฿33.3b

JSP Pharmaceutical Manufacturing (Thailand) Public

SET:JSP

฿968.1m

AFT Pharmaceuticals

NZSE:AFT

NZ$344.0m

Price History & Performance

Summary of all time highs, changes and price drops for T.Man Pharmaceutical
Historical stock prices
Current Share Price	฿17.30
52 Week High	฿19.30
52 Week Low	฿16.40
Beta	0
11 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	5.49%

Recent updates

Shareholder Returns

	TMAN-R	TH Pharmaceuticals	TH Market
7D	n/a	-1.5%	-1.8%
1Y	n/a	15.4%	5.1%

Return vs Industry: Insufficient data to determine how TMAN-R performed against the TH Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how TMAN-R performed against the TH Market.

Price Volatility

Is TMAN-R's price volatile compared to industry and market?
TMAN-R volatility
TMAN-R Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	6.6%
Market Average Movement	5.1%
10% most volatile stocks in TH Market	11.1%
10% least volatile stocks in TH Market	2.5%

Stable Share Price: TMAN-R's share price has been volatile over the past 3 months compared to the TH market.

Volatility Over Time: Insufficient data to determine TMAN-R's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2023	944	n/a	www.tmanpharma.in.th

T.Man Pharmaceutical Public Company Limited manufactures and sells pharmaceuticals and health products. It offers a range of pharmaceutical products, including antibiotics, gastrointestinal drugs, respiratory drugs, musculoskeletal drugs, nervous system drugs, and chronic disease drugs, as well as medicines for the skin in form of tablets, capsules, powders, liquids, and semisolids. The company was incorporated in 2023 and is headquartered in Bangkok, Thailand.

T.Man Pharmaceutical Public Company Limited Fundamentals Summary

How do T.Man Pharmaceutical's earnings and revenue compare to its market cap?
TMAN-R fundamental statistics
Market cap	฿6.92b
Earnings (TTM)	฿419.13m
Revenue (TTM)	฿2.13b

16.5x

P/E Ratio

3.2x

P/S Ratio

Is TMAN-R overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
TMAN-R income statement (TTM)
Revenue	฿2.13b
Cost of Revenue	฿1.13b
Gross Profit	฿997.37m
Other Expenses	฿578.24m
Earnings	฿419.13m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	1.05
Gross Margin	46.82%
Net Profit Margin	19.67%
Debt/Equity Ratio	7.6%

How did TMAN-R perform over the long term?

See historical performance and comparison

T.Man Pharmaceutical SET:TMAN-R Stock Report